Frank Condella
Vorsitzender bei MAYNE PHARMA GROUP LIMITED
Vermögen: 298 393 $ am 30.04.2024
Aktive Positionen von Frank Condella
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MAYNE PHARMA GROUP LIMITED | Independent Dir/Board Member | 30.05.2018 | - |
Vorsitzender | 30.09.2021 | - | |
Direktor/Vorstandsmitglied | 30.05.2018 | 30.09.2021 | |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - |
Karriereverlauf von Frank Condella
Ehemalige bekannte Positionen von Frank Condella
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VECTURA GROUP | Direktor/Vorstandsmitglied | 10.06.2016 | 31.10.2018 |
JUNIPER PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 10.03.2009 | 30.06.2017 |
Vorstandsvorsitzender | 15.12.2009 | 01.08.2016 | |
Independent Dir/Board Member | 06.05.2011 | 12.06.2012 | |
Präsident | 15.12.2009 | 01.08.2016 | |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Corporate Officer/Principal | 01.01.2002 | - |
Alpharma Specialty Pharma LLC
Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Part of Pfizer Inc., Alpharma Specialty Pharma LLC is a company that distributes multi-source injectable pharmaceutical drugs. The company is based in Paramus, NJ. | Präsident | 01.01.2000 | 01.10.2001 |
FH Faulding & Co. Ltd. | Präsident | 01.01.2000 | 01.10.2001 |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
ROCHE HOLDING AG | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ | - | - | |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Frank Condella
Northeastern University | Masters Business Admin |
D'Amore-Mckim School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 9 |
Vereinigtes Königreich | 6 |
Australien | 3 |
Operativ
Director/Board Member | 9 |
Independent Dir/Board Member | 5 |
President | 4 |
Sektoral
Health Technology | 12 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ROCHE HOLDING AG | Health Technology |
MAYNE PHARMA GROUP LIMITED | Health Technology |
Private Unternehmen | 13 |
---|---|
Alpharma Specialty Pharma LLC
Alpharma Specialty Pharma LLC Medical DistributorsDistribution Services Part of Pfizer Inc., Alpharma Specialty Pharma LLC is a company that distributes multi-source injectable pharmaceutical drugs. The company is based in Paramus, NJ. | Distribution Services |
FH Faulding & Co. Ltd. | Health Technology |
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Catalent JNP, Inc.
Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Fulcrum Pharma Plc provides drug development and regulatory expertise essential to progress a development program from research to product approval. The company was founded in 1999 and is headquartered in Hemel Hempstead, the United Kingdom. | Health Technology |
Prosonix Ltd.
Prosonix Ltd. Pharmaceuticals: MajorHealth Technology Prosonix Ltd. engages in the provision of inhaled respiratory medicines. The company was founded by Andre James Bush and David Hipkiss in 2006 and is headquartered in Oxford, the United Kingdom. | Health Technology |
The Polycystic Kidney Disease Research Foundation | |
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
Palladio Biosciences, Inc.
Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Health Technology |
Faulding Pharmaceuticals Plc | |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Consumer Non-Durables |
- Börse
- Insiders
- Frank Condella
- Erfahrung